Blood pressure: the lower, the better: the con side.
作者信息
Grossman Ehud
机构信息
Internal Medicine D and Hypertension Unit, The Chaim Sheba Medical Center, Tel-Hashomer, Affiliated with Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
出版信息
Diabetes Care. 2011 May;34 Suppl 2(Suppl 2):S308-12. doi: 10.2337/dc11-s245.
Abstract
摘要
相似文献
1
Blood pressure: the lower, the better: the con side.
Diabetes Care. 2011 May;34 Suppl 2(Suppl 2):S308-12. doi: 10.2337/dc11-s245.
2
Is there any memory effect of blood pressure lowering in diabetes?
Int J Cardiol. 2011 Sep 15;151(3):384-5. doi: 10.1016/j.ijcard.2011.06.114. Epub 2011 Jul 20.
3
Antihypertensive treatment and blood pressure in diabetic and nondiabetic patients: the lower, the better?
Diabetes Care. 2011 May;34 Suppl 2(Suppl 2):S304-7. doi: 10.2337/dc11-s244.
4
Randomized clinical trials: prescriptions to be applied with caution!
Am J Hypertens. 2008 May;21(5):483-4. doi: 10.1038/ajh.2008.164.
5
[Pharmacotherapeutical features of arterial hypertension in patients with diabetes mellitus].
Klin Med (Mosk). 2007;85(1):52-7.
6
Analysis of recent papers in hypertension. Need for more aggressive blood pressure control in diabetes.
J Clin Hypertens (Greenwich). 2003 Sep-Oct;5(5):352-3. doi: 10.1111/j.1524-6175.2003.03118.x.
7
[Reasons for not intensifying antihypertensive treatment to diabetes in some regions of China].
Zhonghua Yi Xue Za Zhi. 2008 Jan 22;88(4):240-4.
8
Brief comments on the issue of cardiovascular risk in diabetic patients.
Am J Hypertens. 2004 Jul;17(7):640. doi: 10.1016/j.amjhyper.2004.03.677.
9
Blood pressure control and components of the metabolic syndrome: the GOOD survey.
Cardiovasc Diabetol. 2009 Sep 15;8:51. doi: 10.1186/1475-2840-8-51.
10
Blood pressure control in diabetes mellitus: is lower always better, and how low should it go?
Circulation. 2011 Jun 21;123(24):2776-8. doi: 10.1161/CIRCULATIONAHA.111.033704.
引用本文的文献
1
Salt Substitution and Recurrent Stroke and Death: A Randomized Clinical Trial.
JAMA Cardiol. 2025 Apr 1;10(4):343-350. doi: 10.1001/jamacardio.2024.5417.
2
Association of Wearable Device-Measured Step Volume and Variability With Blood Pressure in Older Chinese Adults: Mobile-Based Longitudinal Observational Study.
J Med Internet Res. 2024 Aug 14;26:e50075. doi: 10.2196/50075.
3
Influence of hypertension duration and blood pressure levels on cardiovascular disease and all-cause mortality: A large prospective cohort study.
Front Cardiovasc Med. 2022 Oct 17;9:948707. doi: 10.3389/fcvm.2022.948707. eCollection 2022.
4
Blood Pressure Changes After a Health Promotion Program Among Mexican Workers.
Front Public Health. 2021 Jun 23;9:683655. doi: 10.3389/fpubh.2021.683655. eCollection 2021.
5
Healthcare professional-led interventions on lifestyle modifications for hypertensive patients - a systematic review and meta-analysis.
BMC Fam Pract. 2021 Apr 5;22(1):63. doi: 10.1186/s12875-021-01421-z.
6
Blood pressure targets in adults with hypertension.
Cochrane Database Syst Rev. 2020 Dec 17;12(12):CD004349. doi: 10.1002/14651858.CD004349.pub3.
7
Associations of mortality with own blood pressure using son's blood pressure as an instrumental variable.
Sci Rep. 2019 Jun 20;9(1):8986. doi: 10.1038/s41598-019-45391-w.
8
Efficacy and Safety of S-Amlodipine 2.5 and 5 mg/d in Hypertensive Patients Who Were Treatment-Naive or Previously Received Antihypertensive Monotherapy.
J Cardiovasc Pharmacol Ther. 2018 Jul;23(4):318-328. doi: 10.1177/1074248418769054. Epub 2018 Apr 12.
9
Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial.
Int J Obes (Lond). 2016 Aug;40(8):1310-9. doi: 10.1038/ijo.2016.52. Epub 2016 Mar 23.
10
The effect of an e-health intervention designed to reduce prolonged occupational sitting on mean arterial pressure.
J Occup Environ Med. 2014 Nov;56(11):1189-94. doi: 10.1097/JOM.0000000000000243.
本文引用的文献
1
Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease.
JAMA. 2010 Jul 7;304(1):61-8. doi: 10.1001/jama.2010.884.
2
Effects of intensive blood-pressure control in type 2 diabetes mellitus.
N Engl J Med. 2010 Apr 29;362(17):1575-85. doi: 10.1056/NEJMoa1001286. Epub 2010 Mar 14.
3
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document.
J Hypertens. 2009 Nov;27(11):2121-58. doi: 10.1097/HJH.0b013e328333146d.
4
Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial.
Lancet. 2009 Aug 15;374(9689):525-33. doi: 10.1016/S0140-6736(09)61340-4.
5
Treatment blood pressure targets for hypertension.
Cochrane Database Syst Rev. 2009 Jul 8(3):CD004349. doi: 10.1002/14651858.CD004349.pub2.
6
Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study.
J Hypertens. 2009 Jul;27(7):1360-9. doi: 10.1097/HJH.0b013e32832d7370.
7
Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies.
BMJ. 2009 May 19;338:b1665. doi: 10.1136/bmj.b1665.
8
When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal.
J Hypertens. 2009 May;27(5):923-34. doi: 10.1097/HJH.0b013e32832aa6b5.
9
Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS).
Hypertens Res. 2008 Dec;31(12):2115-27. doi: 10.1291/hypres.31.2115.
10
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.
Lancet. 2008 Sep 27;372(9644):1174-83. doi: 10.1016/S0140-6736(08)61242-8. Epub 2008 Aug 29.
Zotero 插件